Fundacion Oftalmologica
Welcome,         Profile    Billing    Logout  
 0 Trials 
2 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Cobos, Juan Diego Higuera
NOVATION-1, NCT04669015: Phase 3 Inhaled Novaferon Study in Hospitalized Patients With Moderate to Severe COVID-19

Recruiting
3
914
Canada, RoW
Novaferon, Standard of Care, Placebo
Genova Inc.
Covid19
08/22
08/22
STRONG-HF, NCT03412201 / 2018-000486-37: Safety, Tolerability and Efficacy of Rapid Optimization, Helped by NT-proBNP testinG, of Heart Failure Therapies

Recruiting
N/A
1800
Europe, RoW
Usual Care, High Intensity Care
Heart Initiative, Hôpitaux Universitaires Saint-Louis-Lariboisière, Momentum Research, Inc., Roche Diagnostics, Inserm UMRS 942
Heart Failure
10/21
10/21
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Cobos, Juan Diego Higuera
NOVATION-1, NCT04669015: Phase 3 Inhaled Novaferon Study in Hospitalized Patients With Moderate to Severe COVID-19

Recruiting
3
914
Canada, RoW
Novaferon, Standard of Care, Placebo
Genova Inc.
Covid19
08/22
08/22
STRONG-HF, NCT03412201 / 2018-000486-37: Safety, Tolerability and Efficacy of Rapid Optimization, Helped by NT-proBNP testinG, of Heart Failure Therapies

Recruiting
N/A
1800
Europe, RoW
Usual Care, High Intensity Care
Heart Initiative, Hôpitaux Universitaires Saint-Louis-Lariboisière, Momentum Research, Inc., Roche Diagnostics, Inserm UMRS 942
Heart Failure
10/21
10/21

Download Options